CD40L-binding agent based platelet aggregation assays
US9297810B2 · kind B2 · utility
0Cited by
3References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2013 |
| Grant date | Mar 29, 2016 |
| Priority date | — |
| Expiry date | May 15, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/86
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides methods of determining platelet aggregation, methods of determining susceptibility to clotting upon administration of a CD40L-binding moiety, and kits related thereto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.